Evidence map›Paper›PMID 40709186›Full record

ArticleFrontiers in immunology2025

Retroperitoneal fibrosis in presence of autoimmune coagulation factor XIII deficiency result in recurrent critical post-operative hemorrhage: a case report and molecular research with new insights.

Tomonori Matsushita, Mitsuhiro Tachibana, Hiromichi Nakagawa, Shuhei Goto, Koji Nishizawa, Takashi Kobayashi, Shigeki Fukuzawa, Kunihiko Itoh

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomonori MatsushitaDepartment of Urology, Shimada General Medical Center, Shimada, Shizuoka, Japan.
Mitsuhiro TachibanaDepartment of Diagnostic Pathology, Shimada General Medical Center, Shimada, Shizuoka, Japan.
Hiromichi NakagawaDepartment of Urology, Shimada General Medical Center, Shimada, Shizuoka, Japan.
Shuhei GotoDepartment of Urology, Shimada General Medical Center, Shimada, Shizuoka, Japan.
Koji NishizawaDepartment of Urology, Shimada General Medical Center, Shimada, Shizuoka, Japan.
Takashi KobayashiDepartment of Urology, Kyoto University Hospital, Kyoto, Kyoto, Japan.
Shigeki FukuzawaDepartment of Urology, Shimada General Medical Center, Shimada, Shizuoka, Japan.
Kunihiko ItohDepartment of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Idiopathic retroperitoneal fibrosis is an IgG4-related disease where pathological role and clinical significance of IgG4 antibodies remain largely unknown. This report shows a rare case of retroperitoneal fibrosis in presence of Autoimmune coagulation factor XIII deficiency, in which an acute life-threatening hemorrhage was successfully managed with effective treatment strategies. Following this, we investigated the molecular mechanisms underlying the patient's pathology using experimental translational approach. Case presentation and research results: The patient was a 60-year-old Asian man with a retroperitoneal mass. A laparoscopic biopsy confirmed that the lesion was retroperitoneal fibrosis with IgG4-expressing plasma cell infiltration. Though biopsy was completed without complications, the patient experienced repeated life-threatening intraperitoneal bleeding starting the next day. Despite performing one emergency laparotomy and three series of emergency transcatheter arterial embolization along with massive transfusions, achieving hemostasis was difficult. Suspecting a humoral autoimmune hemorrhagic disorder, we performed plasma exchange, which achieved complete hemostasis. Later, an abnormal decrease in the activity of coagulation Factor XIII was observed, leading to the diagnosis of Autoimmune coagulation Factor XIII deficiency. Subsequent treatment with steroids and coagulation Factor XIII concentrates prevented further bleeding. We investigated the potential involvement of IgG4-related disease and the effects of IgG4 on coagulation Factor XIII using an Conclusions: The patient experienced recurrent life-threatening bleeding due to Autoimmune coagulation Factor XIII deficiency, which was successfully controlled through plasma exchange therapy. This is the first reported case of concurrent retroperitoneal fibrosis and Autoimmune coagulation Factor XIII deficiency. Based on the results of our research, it is suggested IgG4 may play a role in the pathology of both disorders. It was hypothesized that this hematological disorder could be a part of the spectrum of IgG4 autoimmune diseases.

Indexed as

Factor XIII DeficiencyImmunoglobulin G4-Related DiseasePostoperative HemorrhageRetroperitoneal FibrosisAutoantibodiesHumansImmunoglobulin GMaleMiddle AgedRecurrenceAutoantibodiesImmunoglobulin Gautoimmune coagulation factor XIII deficiencycase reportIgG4-autoimmune diseaseIgG4-related diseaseplasma exchangepost-operative recurrent bleedingretroperitoneal fibrosis

Identifiers

PMID40709186
PMCPMC12288730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.